Cargando…

Post-Surgical Indications to Radioiodine Treatment and Potential Risk Factors for Post-Treatment Recurrence in Patients with Intermediate-Risk Differentiated Thyroid Carcinoma

In this multicentric retrospective observational study, we investigated the potential risk factors for radioiodine (RAI) indication and the post-treatment recurrence of intermediate-risk differentiated thyroid cancer (DTC) 1 and 3 years from diagnosis. We included 121 patients who underwent thyroide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Mattia, Mele, Chiara, Rossetto Giaccherino, Ruth, Meomartino, Letizia, Brero, Denise, Marsan, Giulia, Aimaretti, Gianluca, Ghigo, Ezio, Pagano, Loredana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220588/ https://www.ncbi.nlm.nih.gov/pubmed/37240945 http://dx.doi.org/10.3390/jpm13050775

Ejemplares similares

Traumatic Brain Injury and Hypopituitarism
por: Aimaretti, Gianluca, et al.
Publicado: (2005)

Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glands
por: Egalini, Filippo, et al.
Publicado: (2022)

Radioiodine (131I) treatment decision-making for low- and intermediate-risk differentiated thyroid cancer
por: Gao, Haiyan, et al.
Publicado: (2023)

Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer—To Treat or Not to Treat
por: van Velsen, Evert F S, et al.
Publicado: (2023)

One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients
por: De Sanctis, Vitaliana, et al.
Publicado: (2020)

Post-radioiodine management of patients with Graves' disease
por: Collins, K, et al.
Publicado: (2012)

Thyroid function in the subacute phase of traumatic brain injury: a potential predictor of post-traumatic neurological and functional outcomes
por: Mele, C., et al.
Publicado: (2021)

The pattern of TSH and fT4 levels across different BMI ranges in a large cohort of euthyroid patients with obesity
por: Mele, Chiara, et al.
Publicado: (2022)

Diagnosis and Treatment of Acute Pleural Effusion following Radioiodine Remnant Ablation Post Lobectomy for Thyroid Cancer
por: Qiu, Xian, et al.
Publicado: (2022)

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer
por: Lorusso, Loredana, et al.
Publicado: (2016)

The relationship between resting energy expenditure and thyroid hormones in response to short-term weight loss in severe obesity
por: Marzullo, Paolo, et al.
Publicado: (2018)

Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations
por: Mele, Chiara, et al.
Publicado: (2020)

Neuroinflammation and Hypothalamo-Pituitary Dysfunction: Focus of Traumatic Brain Injury
por: Mele, Chiara, et al.
Publicado: (2021)

The role of Hashimoto thyroiditis in predicting radioiodine ablation efficacy and prognosis of low to intermediate risk differentiated thyroid cancer
por: Albano, Domenico, et al.
Publicado: (2021)

False-positive radioiodine uptake after radioiodine treatment in differentiated thyroid cancer
por: Barbaro, Daniele, et al.
Publicado: (2023)

Immunomodulatory Effects of Vitamin D in Thyroid Diseases
por: Mele, Chiara, et al.
Publicado: (2020)

Radioiodine treatment for non-toxic goitre
por: Feldt-Rasmussen, Ulla
Publicado: (2009)

Hypothyroidism Following Radioiodine Treatment of Thyrotoxicosis
por: Staffurth, J. S.
Publicado: (1987)

Strategies for Radioiodine Treatment: What’s New
por: Sparano, Clotilde, et al.
Publicado: (2022)

Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer
por: Ha, Seunggyun, et al.
Publicado: (2015)

Efficacy of Low-Dose Radioiodine Ablation in Low- and Intermediate-Risk Differentiated Thyroid Cancer: A Retrospective Comparative Analysis
por: Gómez-Pérez, Ana María, et al.
Publicado: (2020)

Delayed Initial Radioiodine Adjuvant Therapy Does Affect Biochemical Response in Intermediate- to High-Risk Differentiated Thyroid Cancer
por: Yu, Feng, et al.
Publicado: (2021)

The impact of post-radioiodine therapy SPECT/CT on early risk stratification in differentiated thyroid cancer; a bi-institutional study
por: Szujo, Szabina, et al.
Publicado: (2017)

Predictor Analysis in Radiofrequency Ablation of Benign Thyroid Nodules: A Single Center Experience
por: Bisceglia, Alessandro, et al.
Publicado: (2021)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Use of multikinase inhibitors/lenvatinib concomitant with radioiodine for the treatment of radioiodine refractory differentiated thyroid cancer
por: Herranz, Urbano Anido
Publicado: (2022)

Effectiveness of Radioiodine Treatment for Toxic Nodular Goiter
por: Şakı, Hatice, et al.
Publicado: (2015)

Evaluation of Diagnostic Value of SPECT/CT Imaging in Post-radioiodine Therapy in Thyroid Cancer
por: Al Hatmi, Asma, et al.
Publicado: (2022)

Assessment of Different Radioiodine Doses for Post-ablation Therapy of Thyroid Remnants: A Systematic Review
por: Ansari, Mojtaba, et al.
Publicado: (2022)

Unstimulated Serum Thyroglobulin Levels after Thyroidectomy and Radioiodine Therapy for Intermediate-Risk Thyroid Cancer Are Not Always a Reliable Marker of Lymph Node Recurrence: Case Report and a Lesson for Clinicians
por: Foppiani, Luca, et al.
Publicado: (2020)

The BRAF(V600E) mutation in papillary thyroid microcarcinoma with intermediate-risk to high-risk features: does the mutation have an effect on clinical response to radioiodine therapy?
por: Shen, Guohua, et al.
Publicado: (2019)

Radioiodine treatment in McCune–Albright syndrome with hyperthyroidism
por: Chakraborty, Dhritiman, et al.
Publicado: (2012)

Clinical Outcome and Costs of Care in Radioiodine Treatment of Hyperthyroidism
por: Hardisty, C. A., et al.
Publicado: (1990)

Incidence of microcytosis in hyperthyroid cats referred for radioiodine treatment
por: Gil-Morales, Claudia, et al.
Publicado: (2021)

Oxidative stress and radioiodine treatment of differentiated thyroid cancer
por: Buczyńska, Angelika, et al.
Publicado: (2021)

The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Fang, Ya, et al.
Publicado: (2021)

Effect of radioiodine treatment on muscle mass in hyperthyroid cats
por: Xifra, Pilar, et al.
Publicado: (2022)

Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma
por: Li, Fuxin, et al.
Publicado: (2020)

Extremely high doses of radioiodine required for treatment of Graves’ hyperthyroidism: a case report
por: Neto, Arnaldo Moura, et al.
Publicado: (2009)

Circulating adipokines and metabolic setting in differentiated thyroid cancer
por: Mele, Chiara, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uql7tqnav47dcmbhvv6bk7u0dh